What is the 13F Pro Quality Score for PNTG?

13F Pro ranks Pennant Group, Inc. (PNTG) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View PNTG's current score at https://13fpro.ai/company/PNTG (free sign-up required for the full ranking).

Which hedge funds own the most PNTG stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of PNTG include BlackRock,, Van Berkom & Associates, WASATCH ADVISORS. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/PNTG as soon as new 13F filings post.

Where does 13F Pro source PNTG data?

All Pennant Group, Inc. fundamentals and ownership data come directly from SEC EDGAR. Pennant Group, Inc. files with the SEC under CIK 1766400. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is PNTG in?

Pennant Group, Inc. (PNTG) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives PNTG's revenue?

Per Pennant Group, Inc.'s latest 10-Q filed with the SEC on 2026-08-05, the biggest revenue drivers are: Home Health and Hospice Services ($237.4M, +43.2% YoY); Senior Living Services ($60.2M, +12.6% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/PNTG.

What are PNTG's largest expenses?

Pennant Group, Inc.'s latest 10-Q reports these as the largest expense items: Cost of services ($242.6M, +36.9% YoY); General and administrative expense ($21.6M, +22.8% YoY); Rent—cost of services ($13.4M, +12.6% YoY). Sourced directly from SEC EDGAR filing text for Q2 FY2026 (quarter ended June 30, 2026).

How often is PNTG research updated on 13F Pro?

PNTG's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Pennant Group, Inc.(PNTG)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1766400 PNTG stock profile & AI dashboard →

13F Pro Quality Score

62.6/100

Rank #699 of 2,962 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

90.0/100

Profitability

41.6/100

Balance Sheet

62.8/100

Earnings Quality

78.7/100

Free Cash Flow

36.1/100

Institutional Flow

81.1/100

Revenue Scale

51.7/100

Dilution Risk

58.4/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why PNTG Scores 63/100

exact factor attribution · 2026-09-11

PNTG's composite is driven by revenue growth and earnings quality, held back by free cash flow and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+8.0 pts

90th pct

Earnings quality

+2.9 pts

79th pct

Earnings growth

+1.6 pts

82th pct

Institutional flow

+1.6 pts

81th pct

Capital efficiency

+1.3 pts

63th pct

Shareholder dilution

+0.4 pts

58th pct

Scale

+0.3 pts

52th pct

Profitability

-1.3 pts

42th pct

Free cash flow

-2.1 pts

36th pct

Latest change (2026-08-05): 56 → 53 · ↓ Revenue growth 88→78; ↓ Earnings growth 83→64

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

PNTG Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Pennant Group, Inc. (PNTG), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PNTG at 62.6/100 on a 32-signal composite quality model, placing it at rank #699 of 2,962 stocks — the top 25% of the AI-ranked universe. PNTG scores in the top quartile across revenue growth (90.0), institutional flow (81.1), earnings quality (78.7). Areas of concern include free cash flow (36.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Pennant Group, Inc. reports quarterly revenue of $298.0M, net income of $9.1M, an operating margin of 5.8%. Top institutional holders of PNTG by reported 13-F value include BlackRock, Van Berkom & Associates, WASATCH ADVISORS, based on the most recent SEC filings. PNTG trades on the Nasdaq exchange and files with the SEC under CIK 1766400. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PNTG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pennant Group, Inc. directly from SEC EDGAR. Pennant Group, Inc.'s 13F Pro composite quality score has ranged between 37 and 63 since 2021, currently 62.6 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about Pennant Group, Inc.

Quirks, history, and lore behind PNTG — the kind of stuff that makes a stock memorable.

1
The Basics
A U.S. healthcare services company · small-cap · listed on Nasdaq · headquartered in Idaho.
2
The Numbers
Annual revenue in the range of roughly $500 million, spread across hundreds of care locations in more than a dozen states — growth driven largely by acquisitions.
3
The History
Spun off in 2019 from a larger home-health parent, it immediately began building its own portfolio of senior-care businesses as an independent public company.
4
The Secret
It runs a decentralized operating model — local leaders own the culture — which its founders argue produces better outcomes than the corporate-campus-knows-best approach.
5
The Lore
The company sits in Eagle, Idaho — not exactly a healthcare hub — yet it manages a sprawling network of home health, hospice, and senior living communities from the high desert.
6
The Giveaway
Its name evokes a flag flying over a care campus, its ticker is PNTG, and it is laser-focused on senior and post-acute care across the American West and beyond.

▶ Think you know your stocks? Play the Daily Ticker

What's Driving PNTG's Business? Latest 10-Q Breakdown

AI-extracted from Pennant Group, Inc.'s 10-Q filed 2026-08-05 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Biggest Revenue Drivers

Home Health and Hospice Services$237.4M+43.2% YoY

Higher admissions (up 62.3% total, 70.7% Medicare), increased average daily hospice census (up 40.1%), and 38 new agencies added.

Senior Living Services$60.2M+12.6% YoY

Improved average monthly revenue per occupied unit (+3.9%) and eight new communities acquired.

Biggest Revenue Drivers

Total revenue: $298.0M+35.8% YoY

Home Health and Hospice Services$237.4M+43.2% YoY

Higher admissions (up 62.3% total, 70.7% Medicare), increased average daily hospice census (up 40.1%), and 38 new agencies added.

Senior Living Services$60.2M+12.6% YoY

Improved average monthly revenue per occupied unit (+3.9%) and eight new communities acquired.

Largest Expense Items

Cost of services$242.6M+36.9% YoY

Increased volume from higher admissions and census; transition costs related to acquisitions.

General and administrative expense$21.6M+22.8% YoY

Increased payroll, incentives, and related benefits across the growing operations.

Rent—cost of services$13.4M+12.6% YoY

New operating leases for acquired home health, hospice, and senior living properties.

Margins: Operating margin improved to 5.8% from 5.3% despite acquisition-related transitional headwinds and transition services costs of $2.5M. Cost of services increased 60 basis points as a percentage of revenue to 81.4%, driven by higher cost patterns at newly acquired operations, partially offset by leverage gains in existing operations.

Watch Items from the Filing

Medicare and Medicaid revenue concentration: combined 64.3% of Q2 revenue; receivables from these programs 68.9% of total AR as of June 30, 2026.
CMS six-month moratorium on new Medicare enrollment for home health and hospice effective May 13, 2026; heightened scrutiny in Arizona, California, Georgia, Nevada, Oklahoma, Texas.
Transition services costs of $2.5M in Q2 (YTD $5.3M) related to UnitedHealth/Amedisys acquisition integration; expected to continue.
Proposed CY 2027 home health payment increase of only 2.4% and hospice increase of 2.3%; proposed Medicare enrollment restrictions and retroactive revocation rules expand CMS enforcement authority.
Debt increased to $198.5M from $175.0M YTD; available liquidity $145.6M; leverage ratio requires monitoring given acquisition pace.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$298.0M

Net Income

Q2 2026

$9.1M

Free Cash Flow

Q2 2026

$15.5M

Operating Margin

Q2 2026

5.8%

ROIC

Q2 2026

11.4%

D/E Ratio

Q2 2026

0.49

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+36.3% YoY

$947.7MFY 2025

FY22 $473.2MFY23 $544.9MFY24 $695.2MFY25 $947.7M

Net Income

+31.1% YoY

$29.6MFY 2025

FY22 $6.6MFY23 $13.4MFY24 $22.6MFY25 $29.6M

Operating Income

+36.1% YoY

$51.9MFY 2025

FY22 $12.7MFY23 $25.2MFY24 $38.1MFY25 $51.9M

EPS (Diluted)

+20.0% YoY

$0.84FY 2025

FY22 $0.22FY23 $0.44FY24 $0.70FY25 $0.84

Total Assets

+42.5% YoY

$968.2MFY 2025

FY22 $512.1MFY23 $539.7MFY24 $679.5MFY25 $968.2M

Total Debt

$173.8MFY 2025

FY22 $62.9MFY23 $63.9MFY24 $0.00FY25 $173.8M

Op. Cash Flow

+22.9% YoY

$48.3MFY 2025

FY22 $9.0MFY23 $33.1MFY24 $39.3MFY25 $48.3M

Free Cash Flow

+19.6% YoY

$36.3MFY 2025

FY22 $-5.1MFY23 $25.0MFY24 $30.3MFY25 $36.3M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$947.7M +36.3%	$695.2M +27.6%	$544.9M +15.1%	$473.2M +7.6%	$439.7M +12.5%	$391.0M
Net Income	$29.6M +31.1%	$22.6M +68.6%	$13.4M +101.4%	$6.6M +146.4%	$2.7M -82.9%	$15.7M
Operating Income	$51.9M +36.1%	$38.1M +51.4%	$25.2M +97.6%	$12.7M +171.3%	$4.7M -75.2%	$18.9M
EPS (Diluted)	$0.84 +20.0%	$0.70 +59.1%	$0.44 +100.0%	$0.22 +144.4%	$0.09 -82.7%	$0.52
Total Assets	$968.2M +42.5%	$679.5M +25.9%	$539.7M +5.4%	$512.1M -3.4%	$530.3M +4.6%	$507.0M
Total Debt	$173.8M	$0.00 -100.0%	$63.9M +1.6%	$62.9M +22.4%	$51.4M +520.7%	$8.3M
Operating Cash Flow	$48.3M +22.9%	$39.3M +18.8%	$33.1M +265.9%	$9.0M +149.6%	$-18.2M -136.3%	$50.2M
Free Cash Flow	$36.3M +19.6%	$30.3M +21.3%	$25.0M +587.4%	$-5.1M +79.1%	$-24.5M -157.1%	$43.0M

Get alerted when PNTG's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Pennant Group, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of PNTG

BlackRock, Inc.
$109.3M2,959,141 sh
Van Berkom & Associates Inc.
$87.5M2,369,269 sh
WASATCH ADVISORS LP
$69.1M1,870,178 sh
Turtle Creek Asset Management Inc.
$63.3M1,714,462 sh
VANGUARD CAPITAL MANAGEMENT LLC
$54.7M1,480,881 sh
PARADIGM CAPITAL MANAGEMENT INC/NY
$51.8M1,402,800 sh
FMR LLC
$43.7M1,182,138 sh
Provident Investment Management, Inc.
$34.7M939,208 sh
GOLDMAN SACHS GROUP INC
$32.9M891,426 sh
GEODE CAPITAL MANAGEMENT, LLC
$32.8M886,783 sh

Fund	Value	Shares
BlackRock, Inc.	$109.3M	2,959,141
Van Berkom & Associates Inc.	$87.5M	2,369,269
WASATCH ADVISORS LP	$69.1M	1,870,178
Turtle Creek Asset Management Inc.	$63.3M	1,714,462
VANGUARD CAPITAL MANAGEMENT LLC	$54.7M	1,480,881
PARADIGM CAPITAL MANAGEMENT INC/NY	$51.8M	1,402,800
FMR LLC	$43.7M	1,182,138
Provident Investment Management, Inc.	$34.7M	939,208
GOLDMAN SACHS GROUP INC	$32.9M	891,426
GEODE CAPITAL MANAGEMENT, LLC	$32.8M	886,783

Companies Similar to PNTG

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

ADUS

Addus HomeCare Corp

AI score

Similar quality profile · 15 shared holders

WASATCH ADVISORS LP Summit Creek Advisors LLC PEREGRINE CAPITAL MANAGEMENT LLC

GRDN

Guardian Pharmacy Services, Inc.

AI score

Similar quality profile · 10 shared holders

BOONE CAPITAL MANAGEMENT LLC LOOMIS SAYLES & CO L P RIVERBRIDGE PARTNERS LLC

PRVA

Privia Health Group, Inc.

AI score

Similar quality profile · 10 shared holders

Van Berkom & Associates Inc.LOOMIS SAYLES & CO L P RIVERBRIDGE PARTNERS LLC

VMD

VIEMED HEALTHCARE, INC.

AI score

Similar quality profile · 10 shared holders

First Eagle Investment Management, LLC Kent Lake PR LLC RICE HALL JAMES & ASSOCIATES, LLC

HCSG

HEALTHCARE SERVICES GROUP INC

AI score

Similar quality profile · 11 shared holders

First Eagle Investment Management, LLC Pembroke Management, LTD RICE HALL JAMES & ASSOCIATES, LLC

USPH

U S PHYSICAL THERAPY INC /NV

AI score

Similar quality profile · 7 shared holders

Bridge City Capital, LLC RICE HALL JAMES & ASSOCIATES, LLC BARD ASSOCIATES INC

TCMD

TACTILE SYSTEMS TECHNOLOGY INC

AI score

Similar quality profile · 9 shared holders

PARADIGM CAPITAL MANAGEMENT INC/NY GLOBEFLEX CAPITAL L P RICE HALL JAMES & ASSOCIATES, LLC

ATRC

AtriCure, Inc.

AI score

Similar quality profile · 10 shared holders

First Eagle Investment Management, LLC WASATCH ADVISORS LP RICE HALL JAMES & ASSOCIATES, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put PNTG on your watchlist

Track score changes the day Pennant Group, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is PNTG a good stock to buy?

13F Pro's AI-powered analysis of Pennant Group, Inc. (PNTG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PNTG are available on the PNTG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. PNTG is classified as a small company.

Which hedge funds own PNTG?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PNTG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Pennant Group, Inc.'s investment landscape.